Skip to main content
Top
Published in: Neurocritical Care 3/2022

07-07-2022 | Computed Tomography | Original work

Moderate-Severe White Matter Lesion Predicts Delayed Intraventricular Hemorrhage in Intracerebral Hemorrhage

Authors: Mengying Yu, Dongqin Zhu, Zhixian Luo, Zhifang Pan, Yunjun Yang, Haoli Xu

Published in: Neurocritical Care | Issue 3/2022

Login to get access

Abstract

Background

Most existing studies have focused on the correlation between white matter lesion (WML) and baseline intraventricular hemorrhage (IVH) in patients with intracerebral hemorrhage (ICH), whereas few studies have investigated the relationship between WML severity and delayed IVH after admission. This study aimed to investigate the correlation between WML severity and delayed IVH and to verify the association between WML and baseline IVH.

Methods

A total of 480 patients with spontaneous ICH from February 2018 to October 2020 were selected. WML was scored using the Van Swieten Scale, with scores of 0–2 representing nonslight WML and scores of 3–4 representing moderate-severe WML. We determined the presence of IVH on baseline (< 6 h) and follow-up computed tomography (< 72 h) images. Univariate analysis and multiple logistic regression were used to analyze the influencing factors of baseline and delayed IVH.

Results

Among 480 patients with ICH, 172 (35.8%) had baseline IVH, and there was a higher proportion of moderate-severe WML in patients with baseline IVH (20.3%) than in those without baseline IVH (12.7%) (P = 0.025). Among 308 patients without baseline IVH, delayed IVH was found in 40 patients (12.9%), whose proportion of moderate-severe WML (25.0%) was higher than that in patients without delayed IVH (10.8%) (P = 0.012). Multiple logistic regression results showed that moderate-severe WML was independently correlated with baseline IVH (P = 0.006, odds ratio = 2.266, 95% confidence interval = 1.270–4.042) and delayed IVH (P = 0.002, odds ratio = 7.009, 95% confidence interval = 12.086–23.552).

Conclusions

Moderate-severe WML was an independent risk factor for delayed IVH as well as baseline IVH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.PubMedCrossRef Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.PubMedCrossRef
2.
go back to reference Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L. The contribution of small vessel disease to neurodegeneration: focus on Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Int J Mol Sci. 2021;22(9):4958.PubMedPubMedCentralCrossRef Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L. The contribution of small vessel disease to neurodegeneration: focus on Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Int J Mol Sci. 2021;22(9):4958.PubMedPubMedCentralCrossRef
3.
go back to reference Wang Y, Yan X, Zhan J, et al. Neuroimaging markers of cerebral small vessel disease on hemorrhagic transformation and functional outcome after intravenous thrombolysis in patients with acute ischemic stroke: a systematic review and meta-analysis. Front Aging Neurosci. 2021;13:692942.PubMedPubMedCentralCrossRef Wang Y, Yan X, Zhan J, et al. Neuroimaging markers of cerebral small vessel disease on hemorrhagic transformation and functional outcome after intravenous thrombolysis in patients with acute ischemic stroke: a systematic review and meta-analysis. Front Aging Neurosci. 2021;13:692942.PubMedPubMedCentralCrossRef
4.
go back to reference Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.PubMedCrossRef Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.PubMedCrossRef
6.
go back to reference Etherton MR, Wu O, Rost NS. Recent advances in leukoaraiosis: white matter structural integrity and functional outcomes after acute ischemic stroke. Curr Cardiol Rep. 2016;18(12):123.PubMedCrossRef Etherton MR, Wu O, Rost NS. Recent advances in leukoaraiosis: white matter structural integrity and functional outcomes after acute ischemic stroke. Curr Cardiol Rep. 2016;18(12):123.PubMedCrossRef
7.
go back to reference Wong SM, Jansen JFA, Zhang CE, et al. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology. 2019;92(15):e1669–77.PubMedCrossRef Wong SM, Jansen JFA, Zhang CE, et al. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology. 2019;92(15):e1669–77.PubMedCrossRef
8.
9.
go back to reference Chen Y, Yan S, Xu M, Zhong G, Liebeskind DS, Lou M. More extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis. Eur J Neurol. 2018;25(2):380-e15.PubMedCrossRef Chen Y, Yan S, Xu M, Zhong G, Liebeskind DS, Lou M. More extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis. Eur J Neurol. 2018;25(2):380-e15.PubMedCrossRef
10.
go back to reference Lou M, Al-Hazzani A, Goddeau RP, Novak V, Selim M. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke. 2010;41(1):34–40.PubMedCrossRef Lou M, Al-Hazzani A, Goddeau RP, Novak V, Selim M. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke. 2010;41(1):34–40.PubMedCrossRef
11.
go back to reference Sykora M, Herweh C, Steiner T. The association between leukoaraiosis and poor outcome in intracerebral hemorrhage is not mediated by hematoma growth. J Stroke Cerebrovasc Dis. 2017;26(6):1328–33.PubMedCrossRef Sykora M, Herweh C, Steiner T. The association between leukoaraiosis and poor outcome in intracerebral hemorrhage is not mediated by hematoma growth. J Stroke Cerebrovasc Dis. 2017;26(6):1328–33.PubMedCrossRef
12.
go back to reference Hansen BM, Ullman N, Muschelli J, et al. Relationship of white matter lesions with intracerebral hemorrhage expansion and functional outcome: MISTIE II and CLEAR III. Neurocrit Care. 2020;33(2):516–24.PubMedPubMedCentralCrossRef Hansen BM, Ullman N, Muschelli J, et al. Relationship of white matter lesions with intracerebral hemorrhage expansion and functional outcome: MISTIE II and CLEAR III. Neurocrit Care. 2020;33(2):516–24.PubMedPubMedCentralCrossRef
13.
go back to reference Zhang Y, Wang Y, Ji R, et al. In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study. Stroke Vasc Neurol. 2021;6(2):201–6.PubMedCrossRef Zhang Y, Wang Y, Ji R, et al. In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study. Stroke Vasc Neurol. 2021;6(2):201–6.PubMedCrossRef
14.
go back to reference Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.PubMedCrossRef Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.PubMedCrossRef
15.
16.
go back to reference Hallevi H, Albright KC, Aronowski J, et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70(11):848–52.PubMedCrossRef Hallevi H, Albright KC, Aronowski J, et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70(11):848–52.PubMedCrossRef
17.
go back to reference Zhu DQ, Chen Q, Xiang YL, et al. Predicting intraventricular hemorrhage growth with a machine learning-based, radiomics-clinical model. Aging (Albany NY). 2021;13(9):12833–48.CrossRef Zhu DQ, Chen Q, Xiang YL, et al. Predicting intraventricular hemorrhage growth with a machine learning-based, radiomics-clinical model. Aging (Albany NY). 2021;13(9):12833–48.CrossRef
18.
go back to reference Gaberel T, Magheru C, Emery E. Management of non-traumatic intraventricular hemorrhage. Neurosurg Rev. 2012;35(4):485–94 (discussion 494-5).PubMedCrossRef Gaberel T, Magheru C, Emery E. Management of non-traumatic intraventricular hemorrhage. Neurosurg Rev. 2012;35(4):485–94 (discussion 494-5).PubMedCrossRef
19.
go back to reference Kim BJ, Lee SH, Ryu WS, et al. Extents of white matter lesions and increased intraventricular extension of intracerebral hemorrhage. Crit Care Med. 2013;41(5):1325–31.PubMedCrossRef Kim BJ, Lee SH, Ryu WS, et al. Extents of white matter lesions and increased intraventricular extension of intracerebral hemorrhage. Crit Care Med. 2013;41(5):1325–31.PubMedCrossRef
20.
go back to reference Vagal V, Venema SU, Behymer TP, et al. White matter lesion severity is associated with intraventricular hemorrhage in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2020;29(5):104661.PubMedPubMedCentralCrossRef Vagal V, Venema SU, Behymer TP, et al. White matter lesion severity is associated with intraventricular hemorrhage in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2020;29(5):104661.PubMedPubMedCentralCrossRef
21.
go back to reference Witsch J, Bruce E, Meyers E, et al. Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology. 2015;84(10):989–94.PubMedPubMedCentralCrossRef Witsch J, Bruce E, Meyers E, et al. Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology. 2015;84(10):989–94.PubMedPubMedCentralCrossRef
22.
go back to reference Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM. Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology. 2013;80(14):1295–9.PubMedPubMedCentralCrossRef Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM. Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage. Neurology. 2013;80(14):1295–9.PubMedPubMedCentralCrossRef
23.
go back to reference Yogendrakumar V, Ramsay T, Fergusson DA, et al. Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth. Stroke. 2020;51(4):1120–7.PubMedCrossRef Yogendrakumar V, Ramsay T, Fergusson DA, et al. Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth. Stroke. 2020;51(4):1120–7.PubMedCrossRef
24.
go back to reference van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry. 1990;53(12):1080–3.PubMedPubMedCentralCrossRef van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry. 1990;53(12):1080–3.PubMedPubMedCentralCrossRef
25.
go back to reference Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.PubMedPubMedCentralCrossRef Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.PubMedPubMedCentralCrossRef
26.
go back to reference Rodrigues MA, Samarasekera N, Lerpiniere C, et al. Association between computed tomographic biomarkers of cerebral small vessel diseases and long-term outcome after spontaneous intracerebral hemorrhage. Ann Neurol. 2021;89(2):266–79.PubMedCrossRef Rodrigues MA, Samarasekera N, Lerpiniere C, et al. Association between computed tomographic biomarkers of cerebral small vessel diseases and long-term outcome after spontaneous intracerebral hemorrhage. Ann Neurol. 2021;89(2):266–79.PubMedCrossRef
27.
go back to reference Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed tomographic diagnosis of intraventricular hemorrhage. Etiol Progn Radiol. 1982;143(1):91–6. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed tomographic diagnosis of intraventricular hemorrhage. Etiol Progn Radiol. 1982;143(1):91–6.
28.
go back to reference Lee SH, Park KJ, Park DH, Kang SH, Park JY, Chung YG. Factors associated with clinical outcomes in patients with primary intraventricular hemorrhage. Med Sci Monit. 2017;23:1401–12.PubMedPubMedCentralCrossRef Lee SH, Park KJ, Park DH, Kang SH, Park JY, Chung YG. Factors associated with clinical outcomes in patients with primary intraventricular hemorrhage. Med Sci Monit. 2017;23:1401–12.PubMedPubMedCentralCrossRef
30.
go back to reference Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37.PubMedCrossRef Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37.PubMedCrossRef
31.
go back to reference Cusack TJ, Carhuapoma JR, Ziai WC. Update on the treatment of spontaneous intraparenchymal hemorrhage: medical and interventional management. Curr Treat Options Neurol. 2018;20(1):1.PubMedCrossRef Cusack TJ, Carhuapoma JR, Ziai WC. Update on the treatment of spontaneous intraparenchymal hemorrhage: medical and interventional management. Curr Treat Options Neurol. 2018;20(1):1.PubMedCrossRef
32.
go back to reference Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40(3):833–40.PubMedCrossRef Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40(3):833–40.PubMedCrossRef
33.
go back to reference Li Q, Warren AD, Qureshi AI, et al. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol. 2020;88(2):388–95.PubMedPubMedCentralCrossRef Li Q, Warren AD, Qureshi AI, et al. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol. 2020;88(2):388–95.PubMedPubMedCentralCrossRef
34.
go back to reference Alber J, Alladi S, Bae HJ, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimers Dement (N Y). 2019;5:107–17.CrossRef Alber J, Alladi S, Bae HJ, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimers Dement (N Y). 2019;5:107–17.CrossRef
35.
go back to reference Thrippleton MJ, Backes WH, Sourbron S, et al. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement. 2019;15(6):840–58.PubMedPubMedCentralCrossRef Thrippleton MJ, Backes WH, Sourbron S, et al. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement. 2019;15(6):840–58.PubMedPubMedCentralCrossRef
36.
go back to reference Freeze WM, Jacobs HIL, de Jong JJ, et al. White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed. Neurobiol Aging. 2020;85:113–22.PubMedCrossRef Freeze WM, Jacobs HIL, de Jong JJ, et al. White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed. Neurobiol Aging. 2020;85:113–22.PubMedCrossRef
37.
go back to reference Zhang CE, Wong SM, Uiterwijk R, et al. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging. Brain Imaging Behav. 2019;13(2):389–95.PubMedCrossRef Zhang CE, Wong SM, Uiterwijk R, et al. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging. Brain Imaging Behav. 2019;13(2):389–95.PubMedCrossRef
38.
go back to reference Kerkhofs D, Wong SM, Zhang E, et al. Baseline blood-brain barrier leakage and longitudinal microstructural tissue damage in the periphery of white matter hyperintensities. Neurology. 2021;96(17):e2192–200.PubMedPubMedCentralCrossRef Kerkhofs D, Wong SM, Zhang E, et al. Baseline blood-brain barrier leakage and longitudinal microstructural tissue damage in the periphery of white matter hyperintensities. Neurology. 2021;96(17):e2192–200.PubMedPubMedCentralCrossRef
39.
go back to reference Burchell SR, Tang J, Zhang JH. Hematoma expansion following intracerebral hemorrhage: mechanisms targeting the coagulation cascade and platelet activation. Curr Drug Targets. 2017;18(12):1329–44.PubMedPubMedCentralCrossRef Burchell SR, Tang J, Zhang JH. Hematoma expansion following intracerebral hemorrhage: mechanisms targeting the coagulation cascade and platelet activation. Curr Drug Targets. 2017;18(12):1329–44.PubMedPubMedCentralCrossRef
40.
go back to reference Yu S, Arima H, Heeley E, et al. White blood cell count and clinical outcomes after intracerebral hemorrhage: the INTERACT2 trial. J Neurol Sci. 2016;361:112–6.PubMedCrossRef Yu S, Arima H, Heeley E, et al. White blood cell count and clinical outcomes after intracerebral hemorrhage: the INTERACT2 trial. J Neurol Sci. 2016;361:112–6.PubMedCrossRef
41.
go back to reference Tu S, Zhao R, Fang H, Wang L, Shao A, Sheng J. Association between non-alcoholic fatty liver disease and intracerebral hemorrhage. Cell Transpl. 2019;28(8):1033–8.CrossRef Tu S, Zhao R, Fang H, Wang L, Shao A, Sheng J. Association between non-alcoholic fatty liver disease and intracerebral hemorrhage. Cell Transpl. 2019;28(8):1033–8.CrossRef
42.
go back to reference Kim HC, Oh SM, Pan WH, et al. Association between alanine aminotransferase and intracerebral hemorrhage in East Asian populations. Neuroepidemiology. 2013;41(2):131–8.PubMedCrossRef Kim HC, Oh SM, Pan WH, et al. Association between alanine aminotransferase and intracerebral hemorrhage in East Asian populations. Neuroepidemiology. 2013;41(2):131–8.PubMedCrossRef
43.
go back to reference Tan G, Hao Z, Lei C, et al. Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage. Neurol Sci. 2016;37(10):1693–700.PubMedCrossRef Tan G, Hao Z, Lei C, et al. Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage. Neurol Sci. 2016;37(10):1693–700.PubMedCrossRef
44.
go back to reference Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37(1):256–62.PubMedCrossRef Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006;37(1):256–62.PubMedCrossRef
45.
go back to reference Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-33.PubMed Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-33.PubMed
Metadata
Title
Moderate-Severe White Matter Lesion Predicts Delayed Intraventricular Hemorrhage in Intracerebral Hemorrhage
Authors
Mengying Yu
Dongqin Zhu
Zhixian Luo
Zhifang Pan
Yunjun Yang
Haoli Xu
Publication date
07-07-2022
Publisher
Springer US
Published in
Neurocritical Care / Issue 3/2022
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-022-01543-x

Other articles of this Issue 3/2022

Neurocritical Care 3/2022 Go to the issue